10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2013 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 11, 2014) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Net revenues | $ 126,761 | 123,120 | 107,080 |
| Cost of revenues | 102,978 | 100,632 | 86,518 |
| Gross profit | 23,783 | 22,488 | 20,562 |
| Operating expenses | 15,746 | 15,278 | 14,231 |
| Operating profit | 8,037 | 7,210 | 6,331 |
| Interest expense, net | 509 | 557 | 584 |
| Loss on early extinguishment of debt | 0 | 348 | 0 |
| Income before income tax provision | 7,528 | 6,305 | 5,747 |
| Income tax provision | 2,928 | 2,436 | 2,258 |
| Income from continuing operations | 4,600 | 3,869 | 3,489 |
| Loss from discontinued operations, net of tax | (8) | (7) | (31) |
| Net income | 4,592 | 3,862 | 3,458 |
| Net loss attributable to noncontrolling interest | 0 | 2 | 4 |
| Net income attributable to CVS Caremark | 4,592 | 3,864 | 3,462 |
| Basic earnings per common share: | |||
| Income from continuing operations attributable to CVS Caremark (in dollars per share) | 3.78 | 3.05 | 2.61 |
| Loss from discontinued operations attributable to CVS Caremark (in dollars per share) | (0.01) | (0.01) | (0.02) |
| Net income attributable to CVS Caremark (in dollars per share) | 3.77 | 3.04 | 2.59 |
| Weighted average common shares outstanding (in shares) | 1,217 | 1,271 | 1,338 |
| Diluted earnings per common share: | |||
| Income from continuing operations attributable to CVS Caremark (in dollars per share) | 3.75 | 3.02 | 2.59 |
| Loss from discontinued operations attributable to CVS Caremark (in dollars per share) | (0.01) | (0.01) | (0.02) |
| Net income attributable to CVS Caremark (in dollars per share) | 3.74 | 3.02 | 2.57 |
| Weighted average common shares outstanding (in shares) | 1,226 | 1,280 | 1,347 |
| Dividends declared per common share | 0.90 | 0.65 | 0.50 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2013 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 11, 2014) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Net income | $ 4,592 | 3,862 | 3,458 |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustments, net of tax | (30) | 0 | 0 |
| Net cash flow hedges, net of income tax | 3 | 3 | (9) |
| Pension and other postretirement benefits, net of income tax | 59 | (12) | (20) |
| Net other comprehensive income (loss) | 32 | (9) | (29) |
| Comprehensive income | 4,624 | 3,853 | 3,429 |
| Comprehensive loss attributable to noncontrolling interest | 0 | 2 | 4 |
| Comprehensive income attributable to CVS Caremark | 4,624 | 3,855 | 3,433 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2013 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 11, 2014) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 114,993 | 113,205 | 97,688 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (91,178) | (90,032) | (75,148) |
| Cash paid to other suppliers and employees | (14,295) | (13,643) | (13,635) |
| Interest received | 8 | 4 | 4 |
| Interest paid | (534) | (581) | (647) |
| Income taxes paid | (3,211) | (2,282) | (2,406) |
| Net cash provided by operating activities | 5,783 | 6,671 | 5,856 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (1,984) | (2,030) | (1,872) |
| Proceeds from sale-leaseback transactions | 600 | 529 | 592 |
| Proceeds from sale of property and equipment and other assets | 54 | 23 | 4 |
| Acquisitions (net of cash acquired) and other investments | (415) | (378) | (1,441) |
| Purchase of available-for-sale investments | (226) | 0 | (3) |
| Maturity of available-for-sale investments | 136 | 0 | 60 |
| Proceeds from sale of subsidiary | 0 | 7 | 250 |
| Net cash used in investing activities | (1,835) | (1,849) | (2,410) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (690) | (60) | 450 |
| Proceeds from issuance of long-term debt | 3,964 | 1,239 | 1,463 |
| Repayments of long-term debt | 0 | (1,718) | (2,122) |
| Purchase of noncontrolling interest in subsidiary | 0 | (26) | 0 |
| Dividends paid | (1,097) | (829) | (674) |
| Derivative settlements | 0 | 0 | (19) |
| Proceeds from exercise of stock options | 500 | 836 | 431 |
| Excess tax benefits from stock-based compensation | 62 | 28 | 21 |
| Repurchase of common stock | (3,976) | (4,330) | (3,001) |
| Other | 0 | 0 | (9) |
| Net cash used in financing activities | (1,237) | (4,860) | (3,460) |
| Effect of exchange rate changes on cash and cash equivalents | 3 | 0 | 0 |
| Net increase (decrease) in cash and cash equivalents | 2,714 | (38) | (14) |
| Cash and cash equivalents at the beginning of the year | 1,375 | 1,413 | |
| Cash and cash equivalents at the end of the year | 4,089 | 1,375 | 1,413 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 4,592 | 3,862 | 3,458 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,870 | 1,753 | 1,568 |
| Stock-based compensation | 141 | 132 | 135 |
| Loss on early extinguishment of debt | 0 | 348 | 0 |
| Gain on sale of subsidiary | 0 | 0 | (53) |
| Deferred income taxes and other noncash items | (86) | (111) | 144 |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (2,210) | (387) | (748) |
| Inventories | 12 | (853) | 586 |
| Other current assets | 105 | 3 | (420) |
| Other assets | (135) | (99) | (49) |
| Accounts payable and claims and discounts payable | 1,024 | 1,147 | 1,128 |
| Accrued expenses | 471 | 766 | 105 |
| Other long-term liabilities | (1) | 110 | 2 |
| Net cash provided by operating activities | 5,783 | 6,671 | 5,856 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2013 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2013 10-K (Filed: Feb 11, 2014) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2013 | Dec 31, 2012 | |
| Assets: | ||
| Cash and cash equivalents | $ 4,089 | 1,375 |
| Short-term investments | 88 | 5 |
| Accounts receivable, net | 8,729 | 6,479 |
| Inventories | 11,045 | 11,032 |
| Deferred income taxes | 902 | 693 |
| Other current assets | 472 | 577 |
| Total current assets | 25,325 | 20,161 |
| Property and equipment, net | 8,615 | 8,632 |
| Goodwill | 26,542 | 26,395 |
| Intangible assets, net | 9,529 | 9,753 |
| Other assets | 1,515 | 1,280 |
| Total assets | 71,526 | 66,221 |
| Liabilities: | ||
| Accounts payable | 5,548 | 5,070 |
| Claims and discounts payable | 4,548 | 3,974 |
| Accrued expenses | 4,768 | 4,411 |
| Short-term debt | 0 | 690 |
| Current portion of long-term debt | 561 | 5 |
| Total current liabilities | 15,425 | 14,150 |
| Long-term debt | 12,841 | 9,133 |
| Deferred income taxes | 3,901 | 3,784 |
| Other long-term liabilities | 1,421 | 1,501 |
| Commitments and contingencies (Note 12) | 0 | 0 |
| Shareholders equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | ||
| Common stock, par value $0.01: 3,200 shares authorized; 1,680 shares issued and 1,180 shares outstanding at December 31, 2013 and 1,667 shares issued and 1,231 shares outstanding at December 31, 2012 | 17 | 17 |
| Treasury stock, at cost: 500 shares at December 31, 2013 and 435 shares at December 31, 2012 | (20,169) | (16,270) |
| Shares held in trust: 1 share at December 31, 2013 and 2012 | (31) | (31) |
| Capital surplus | 29,777 | 29,120 |
| Retained earnings | 28,493 | 24,998 |
| Accumulated other comprehensive loss | (149) | (181) |
| Total shareholders equity | 37,938 | 37,653 |
| Total liabilities and shareholders equity | 71,526 | 66,221 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2013 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |